<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00734929</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00001404</org_study_id>
    <nct_id>NCT00734929</nct_id>
  </id_info>
  <brief_title>Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy</brief_title>
  <official_title>A Comparison of the Combination of Aprepitant and Dexamethasone Versus the Combination of Ondansetron and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Craniotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize that the combination of aprepitant with dexamethasone will provide
      significantly improved prophylaxis against Postoperative nausea and vomiting compared with
      the combination of ondansetron and dexamethasone, in patients undergoing craniotomy under
      general anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Incidence of Emesis</measure>
    <time_frame>48 h</time_frame>
    <description>Any vomiting or retching</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Nausea</measure>
    <time_frame>Post operative procedure (OP) hours (0-2, 24, 48)</time_frame>
    <description>operative procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Vomiting (Post OP)</measure>
    <time_frame>Post OP (0 - 2 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Vomiting (24 Hours)</measure>
    <time_frame>24 h</time_frame>
    <description>Any vomiting or retching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Rescue Antiemetics (Post OP)</measure>
    <time_frame>Post OP (0 - 2 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Rescue Antiemetics (24 Hours)</measure>
    <time_frame>24 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Rescue Antiemetics (48 Hours)</measure>
    <time_frame>48 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With a Complete Response Rate</measure>
    <time_frame>24 hours Post OP, 48 hours Post OP</time_frame>
    <description>complete response rate: defined as no Postoperative nausea and vomiting (PONV) and no need for rescue antiemetics.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Nausea Score</measure>
    <time_frame>Post OP hours 0-2, 24 h, 48 h</time_frame>
    <description>Participants verbally rated their nausea on a scale of 0-10. 0 = No nausea, 10 = worst nausea imaginable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Vomiting Episodes</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Vomiting</measure>
    <time_frame>48 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Rated Their Satisfaction With Antiemetic Management as &quot;Very Satisfied&quot;</measure>
    <time_frame>48 hour</time_frame>
    <description>Participants rated their satisfaction with antiemetic management on a 5 points scale: very satisfied, somewhat satisfied, neither satisfied nor dissatisfied, somewhat dissatisfied, very dissatisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">115</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ondansetron 4 mg within 30 min of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aprepitant + Dexamethasone</intervention_name>
    <description>Aprepitant 40 mg + Dexamethasone 10 mg</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron + Dexamethasone</intervention_name>
    <description>Ondansetron 4 mg + Dexamethasone 10 mg</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A patient is eligible for inclusion in this study if all of the following criteria apply:

          -  Age: 18-75 years of age

          -  Surgery: craniotomy under general anesthesia.

          -  American Society of Anesthesiologists (ASA) Status: ASA: I, II, or III

          -  Language: Fluent in the English language

          -  Informed Consent: Written informed consent must be obtained.

        Exclusion Criteria:

        A patient will not be eligible for inclusion in this study if any one or more of the
        following criteria apply within thirty days of patient enrollment in this clinical trial:

          -  Medical: Any condition that may impair a patient's ability to complete any of the
             study assessments or confound interpretation of results.

          -  Hypersensitivity: Patient has a known immediate or delayed hypersensitivity reaction
             or known idiosyncrasy to any of the two study medications, ondansetron, or aprepitant.

          -  Other Drugs: Patients should not be taking medications with known antiemetic
             properties (phenothiazines, butyrophenones, antihistamines), nor should they receive
             metoclopramide, or other antiemetics preoperatively or 12 hours before the scheduled
             surgical procedure.

          -  Pregnant or lactating females: A pregnancy test will be performed within 24 hours of
             entering the study for females of childbearing potential.

          -  Substance Abuse: Clinically significant abuse of substances (alcohol, illicit or
             prescribed medications) such that the patient is unable to provide informed consent or
             reliably complete any of the study assessments.

          -  Psychiatric Disease: History of a psychiatric illness that may impair the patient's
             ability to provide informed consent or complete any of the study assessments.

          -  Nausea verbal rating score (VRS): A VRS nausea score &gt; 3 (scale 0-10) in the
             preoperative holding area before pretreatment with the study medications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashraf S Habib, MBBCH, FRCA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Habib AS, Keifer JC, Borel CO, White WD, Gan TJ. A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy. Anesth Analg. 2011 Apr;112(4):813-8. doi: 10.1213/ANE.0b013e3181ff47e2. Epub 2010 Nov 16.</citation>
    <PMID>21081776</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2008</study_first_submitted>
  <study_first_submitted_qc>August 13, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2008</study_first_posted>
  <results_first_submitted>April 7, 2011</results_first_submitted>
  <results_first_submitted_qc>May 5, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 3, 2011</results_first_posted>
  <last_update_submitted>January 31, 2017</last_update_submitted>
  <last_update_submitted_qc>January 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PONV</keyword>
  <keyword>nausea</keyword>
  <keyword>emesis</keyword>
  <keyword>antiemetics</keyword>
  <keyword>aprepitant</keyword>
  <keyword>ondansetron</keyword>
  <keyword>dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Aprepitant</mesh_term>
    <mesh_term>Fosaprepitant</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study took place at Duke University Medical Center from September 2007 to June 2009, 146 signed the consent form, 115 were randomized, 104 completed the study</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Aprepitant</title>
          <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
        </group>
        <group group_id="P2">
          <title>Ondansetron</title>
          <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No intervention/ screen fail</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Aprepitant</title>
          <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
        </group>
        <group group_id="B2">
          <title>Ondansetron</title>
          <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="57"/>
            <count group_id="B2" value="58"/>
            <count group_id="B3" value="115"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="115"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51" spread="13"/>
                    <measurement group_id="B2" value="48" spread="13"/>
                    <measurement group_id="B3" value="50" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cumulative Incidence of Emesis</title>
        <description>Any vomiting or retching</description>
        <time_frame>48 h</time_frame>
        <population>ITT analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Cumulative Incidence of Emesis</title>
          <description>Any vomiting or retching</description>
          <population>ITT analysis</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Nausea</title>
        <description>operative procedure</description>
        <time_frame>Post operative procedure (OP) hours (0-2, 24, 48)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Nausea</title>
          <description>operative procedure</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0-2 hours Post OP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 Hours Post Op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 Hours Post Op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Vomiting (Post OP)</title>
        <time_frame>Post OP (0 - 2 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Vomiting (Post OP)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Vomiting (24 Hours)</title>
        <description>Any vomiting or retching</description>
        <time_frame>24 h</time_frame>
        <population>ITT analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Vomiting (24 Hours)</title>
          <description>Any vomiting or retching</description>
          <population>ITT analysis</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Use of Rescue Antiemetics (Post OP)</title>
        <time_frame>Post OP (0 - 2 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Rescue Antiemetics (Post OP)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Use of Rescue Antiemetics (24 Hours)</title>
        <time_frame>24 h</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Rescue Antiemetics (24 Hours)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Use of Rescue Antiemetics (48 Hours)</title>
        <time_frame>48 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Rescue Antiemetics (48 Hours)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With a Complete Response Rate</title>
        <description>complete response rate: defined as no Postoperative nausea and vomiting (PONV) and no need for rescue antiemetics.</description>
        <time_frame>24 hours Post OP, 48 hours Post OP</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Complete Response Rate</title>
          <description>complete response rate: defined as no Postoperative nausea and vomiting (PONV) and no need for rescue antiemetics.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>24 Hours Post OP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 Hours Post OP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Nausea Score</title>
        <description>Participants verbally rated their nausea on a scale of 0-10. 0 = No nausea, 10 = worst nausea imaginable</description>
        <time_frame>Post OP hours 0-2, 24 h, 48 h</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Average Nausea Score</title>
          <description>Participants verbally rated their nausea on a scale of 0-10. 0 = No nausea, 10 = worst nausea imaginable</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0-2 hours post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" lower_limit="0" upper_limit="2.8"/>
                    <measurement group_id="O2" value="0.6" lower_limit="0" upper_limit="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" lower_limit="0" upper_limit="3.2"/>
                    <measurement group_id="O2" value="1.3" lower_limit="0" upper_limit="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" lower_limit="0" upper_limit="3.2"/>
                    <measurement group_id="O2" value="1.1" lower_limit="0" upper_limit="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Vomiting Episodes</title>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Vomiting Episodes</title>
          <units>vomiting episodes</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Vomiting</title>
        <time_frame>48 h</time_frame>
        <population>The analysis population only includes participants who had vomiting and had a complete data set</population>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant + Dexamethasone</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia
Aprepitant + Dexamethasone: Aprepitant 40 mg + Dexamethasone 10 mg</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron + Dexamethasone</title>
            <description>Ondansetron 4 mg within 30 min of the end of surgery + Dexamethasone 10 mg after induction of anesthesia
Ondansetron + Dexamethasone: Ondansetron 4 mg + Dexamethasone 10 mg</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Vomiting</title>
          <population>The analysis population only includes participants who had vomiting and had a complete data set</population>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.5" lower_limit="0.5" upper_limit="28.9"/>
                    <measurement group_id="O2" value="2" lower_limit="0.5" upper_limit="19.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Rated Their Satisfaction With Antiemetic Management as &quot;Very Satisfied&quot;</title>
        <description>Participants rated their satisfaction with antiemetic management on a 5 points scale: very satisfied, somewhat satisfied, neither satisfied nor dissatisfied, somewhat dissatisfied, very dissatisfied)</description>
        <time_frame>48 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aprepitant</title>
            <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Ondansetron</title>
            <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Rated Their Satisfaction With Antiemetic Management as &quot;Very Satisfied&quot;</title>
          <description>Participants rated their satisfaction with antiemetic management on a 5 points scale: very satisfied, somewhat satisfied, neither satisfied nor dissatisfied, somewhat dissatisfied, very dissatisfied)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Aprepitant</title>
          <description>Aprepitant 40 mg preoperatively + dexamethasone 10 mg after induction of anesthesia</description>
        </group>
        <group group_id="E2">
          <title>Ondansetron</title>
          <description>Ondansetron 4 mg within 30 minutes of the end of surgery + Dexamethasone 10 mg after induction of anesthesia</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ashraf Habib</name_or_title>
      <organization>Duke University Medical Center</organization>
      <phone>9196686265</phone>
      <email>habib001@mc.duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

